Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Oct;34(10):6852-6861.
doi: 10.1007/s00330-024-10614-w. Epub 2024 Mar 28.

Efficacy of microwave ablation in the treatment of large benign thyroid nodules: a multi-center study

Affiliations
Multicenter Study

Efficacy of microwave ablation in the treatment of large benign thyroid nodules: a multi-center study

Yuan-Cheng Cang et al. Eur Radiol. 2024 Oct.

Abstract

Objective: To evaluate the efficacy, safety, and improvement of symptoms by ultrasound-guided microwave ablation (MWA) for patients with large benign thyroid nodules (BTNs).

Methods: Eighty-seven patients with 87 BTNs (≥ 4 cm) treated with MWA between April 2015 and March 2021 were enrolled in this retrospective multicenter study, with clinical and ultrasound examinations performed at the 1st, 3rd, 6th, and 12th months. A multivariable linear mixed effects model was employed to explore the alterations in volume and volume reduction ratio (VRR), as well as the potential factors associated with VRR.

Results: The mean age of the 87 patients was 45.69 ± 14.21 years (range 18-76 years), and the ratio of men to women was 1:4.8. The mean volumes were much decreased at the 12th month after ablation compared to the initial volumes (p < .001). The mean VRR was 76.09% at the 12th month. The technique efficacy (VRR > 50%) was 90.80% at the 12th month. A multivariate analysis revealed that VRR was related to the initial volume (p = .015), annular flow (p = .010), and nodule composition (p = .024). The mean symptomatic score decreased from 4.40 ± 0.28 to 0.26 ± 0.06 at the 12th month (p < .001). At the same time, the mean cosmetic score decreased from 3.22 ± 0.10 to 1.31 ± 0.08 (p < .001).

Conclusion: MWA could serve as a safe and effective therapy for large BTNs, significantly reducing the volume of BTNs and significantly improving compressive symptoms and appearance problems.

Clinical relevance statement: Microwave ablation could serve as a safe and effective therapy for large benign thyroid nodules, leading to significant volume reduction and satisfied symptom and cosmetic alleviation period.

Key points: • This multicenter study investigated the feasibility and safety of microwave ablation for large benign thyroid nodules. • After ablation, the nodule volume was significantly reduced, and patients' symptoms and appearance problems were significantly improved. • Microwave ablation is feasible for large benign thyroid nodules and has been a supplement treatment.

Keywords: Ablation techniques; Complications; Multicenter studies; Thyroid nodules; Ultrasonography.

PubMed Disclaimer

References

    1. Radzina M, Cantisani V, Rauda M et al (2017) Update on the role of ultrasound guided radiofrequency ablation for thyroid nodule treatment. Int J Surg 41(Suppl 1):S82-s93 - DOI - PubMed
    1. Hegedüs L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351:1764–1771 - DOI - PubMed
    1. Papini E, Monpeyssen H, Frasoldati A, Hegedüs L (2020) 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. Eur Thyroid J 9:172–185 - DOI - PubMed - PMC
    1. Kim JH, Baek JH, Lim HK et al (2018) 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol 19:632–655 - DOI - PubMed - PMC
    1. Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133 - DOI - PubMed - PMC

Publication types

LinkOut - more resources